Genetic polymorphisms of the IL10 promoter region have been implicated in many autoimmune diseases, including seronegative spondyloarthropathies. We studied three SNPs (IL10-1087, À824, and À597) and two microsatellites (IL10R and IL10G) lying within the promoter region of IL10 for association with susceptibility to and clinical manifestations of ankylosing spondylitis (AS), a common form of spondyloarthritis. Four hundred and sixty-eight individuals from 182 Finnish families affected with AS were studied. No association between individual IL10 promoter region polymorphisms or marker haplotype was observed with susceptibility to AS, but weak association was noted between the IL10-597 and À824 SNPs and age of disease onset (P ¼ 0.01 for each SNP). The IL10.G4 allele was associated with BASFI (corrected for disease duration) (P ¼ 0.03). We conclude that IL10 promoter polymorphisms have no significant effect on susceptibility to AS, but may play a minor role in determining age of disease onset and disease severity.
Ankylosing spondylitis (AS) is a common inflammatory arthritis which is the archetypic disease of a group of related conditions termed 'spondyloarthropathies' (SpA). These diseases are characterised by axial arthritis, enthesitis (inflammation at the attachment point of tendons and ligaments to bone), association with HLA-B27 and other clinical features. Other spondylarthropathies include reactive arthritis, psoriatic arthritis and colitic arthritis. Both susceptibility to AS and its severity are largely genetically determined, 1,2 and the genes responsible are mostly unknown. The cytokine secretion pattern in AS has a Th2 pattern, with impairment of Th1 cytokine production. 3 Interleukin 10 (IL10) secretion by CD8 lymphocytes is significantly higher in AS patients than in either B27-positive or negative controls. 4 IL10 inhibits the secretion of a variety of proinflammatory cytokines including IL1, IL6, IL8 and TNF-alpha, generally suppressing secretion of Th1 cytokines. Secretion of IL10 is itself significantly heritable, 5 and polymorphisms in the 5 0 promoter region have been demonstrated to affect IL10 secretion levels. 6 Association of alleles of the IL10G promoter region microsatellite has previously been reported in Finnish patients with reactive arthritis. 7 In this study, the G10 (allele 10 of the IL10G microsatellite) and G12 alleles were underrepresented in reactive arthritis patients compared with healthy controls, and the G8 allele was associated with a lower likelihood of developing chronic arthritis. The aim of the current study is to investigate the role of IL10 in susceptibility to AS, and its clinical manifestations.
Four hundred and sixty-eight individuals from 182 families affected with AS were recruited from the Rheumatism Foundation Hospital in Heinola, Finland. Apart from 16 families with affected sibling pairs and 15 parent-case affected pairs, all families were singly affected. Fourteen families had members from three generations. Of the remaining 168 two-generation families, 39 had both parents available, 43 had one parent available (of which 26 families had more than one sibling available), and 86 had neither parent available (of which 48 had more than one sibling available). AS was defined according to the modified New York diagnostic criteria. 8 Genomic DNA was extracted from peripheral venous blood by standard methods. A structured questionnaire was used to assess the age of symptom onset, age at diagnosis, disease duration and disease severity scores (including the Bath AS Disease Activity Index (BASDAI), 9 and the Bath AS Functional Index (BASFI). 10 All individuals were genotyped for the IL10 R and G microsatellites (located at 4.0 and 1.1 kb upstream of exon 1) and three promoter region SNPs (-1087, À824 and -597 bp upstream of exon 1). The microsatellites were genotyped using previously reported protocols on Applied Biosystems 377 semiautomated genotypers. 7 All gels were run with previously sequenced control samples of known length to ensure accurate measurement of PCR product length. The IL10-1087 and -597 promoter polymorphisms were genotyped by PCR/ restriction digest as previously described. 7 The -824 polymorphism was genotyped by PCR-amplification refractory mutation system (PCR-ARMS). Fragments were amplified using 100 ng of genomic DNA, 0. 
min (three cycles).
Amplicons were resolved on a 1% agarose gel, stained with ethidium bromide and visualised under ultraviolet light.
Association of the IL10 polymorphisms with disease susceptibility, age of disease onset, BASDAI and BASFI was assessed by within-family methods, using the program 'Transmit' 11 for categorical variables and QTDT 12 for continuous variables. Using both packages, association was examined independent of linkage (in 'Transmit' by using the robust variance option; in QTDT by inclusion of the linkage component in both the full and null hypothesis). Haplotypes of 2-4 markers in length were studied using 'Transmit', which estimates haplotypic frequencies using the observed allele frequency and genotype data. 'Transmit' assumes no recombination between markers. An obligate recombination was observed in one family between markers IL10-824 and IL10-597, and was therefore excluded from haplotype analysis.
Transmitted and untransmitted marker and SNP haplotype frequencies estimated using 'Transmit' are given in Tables 1 and 2 . By within-family means, no association was noted between any SNP or microsatellite, or marker haplotype and AS.
Significant differences were noted between our observed IL10G and IL10R marker frequencies and those observed previously in the Finnish population. 7 The untransmitted allele frequencies for IL10G were very similar to the frequencies noted from patients with reactive arthritis, and significantly different from the healthy control values observed in that study. This study does not support the conclusion that IL10G alleles are associated with susceptibility to reactive arthritis.
Previous studies 6, 7 only identified four IL10R alleles, whereas we observed five alleles, including a hitherto unreported allele 2 bp shorter than the shortest previously reported allele. In contrast to the previous Finnish study, 7 we found that the 111 bp IL10R allele was rare, as it is in other European populations. 6 Previous smaller studies of European populations have only observed three of the possible eight promoter SNP haplotypes (GCC, ACC and ATA). 6 In this study, two further rare haplotypes were also identified (ATC and GTA). The GTA haplotype has also been observed as a rare haplotype in southern Chinese. 13 Although these were uncommon, their existence complicates assignment of IL10 promoter SNP haplotypes where no parental genotype data are available.
Using the program QTDT, a weak association was noted between the IL10-597 and À824 SNPs and age of disease onset (P ¼ 0.01 for each SNP). The IL10.G4 allele was associated with BASFI (corrected for disease duration) (P ¼ 0.03) but was not associated with BASDAI (P ¼ 0.08).
Our study suggests that IL10 has at most a negligible role in AS, perhaps contributing to a minor extent to determining the age of disease onset and disease severity. The levels of significance obtained for the positive associations identified were only marginally significant, and will require confirmation. 
